DeCell Technologies
The web page emphasizes that DeCell Technologies stands as a pioneering biomedical technology company specializing in advanced tissue products for wound healing and surgical reconstructions. Their innovative prECM™ technology facilitates the creation of sterile and secure biological scaffolds, promoting effective tissue regeneration.
Summary
- Innovation from Nova Scotia: DeCell Technologies, headquartered in Nova Scotia, Canada, is at the forefront of biomedical technology.
- Tissue Expertise: Specializing in advanced tissue products, the company is a key player in the realms of wound healing and surgical reconstructions.
- PrECM™ Technology: DeCell employs its patented prECM™ technology to process donated human tissue. This method selectively removes cellular components while preserving the essential structural protein matrix.
- Sterile Solutions: The prECM™ process deactivates and eliminates potential bacteria and viruses, resulting in a sterile and secure biological scaffold.
- Regenerative Impact: The implanted biological scaffold plays a crucial role in fostering tissue regeneration in patients, contributing to improved health outcomes.
- In-House Excellence: DeCell Technologies takes pride in developing unique automated manufacturing equipment in-house. This commitment ensures the quality and consistency of their products at an economical cost.
Error: Contact form not found.
